(Q71650601)

English

Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatment

scientific article published on September 30, 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatment (English)

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

R. D. Ennis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523342

16 May 2024

S. D. Flynn

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523342

16 May 2024

D. B. Fischer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523342

16 May 2024

R. E. Peschel

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523342

16 May 2024

language of work or name

0 references

publication date

1 September 1994

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

30 September 1994

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7523342

16 May 2024

full work available at URL

https://api.elsevier.com/content/article/PII:0360301694900108?httpAccept=text/xml

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

https://api.elsevier.com/content/article/PII:0360301694900108?httpAccept=text/plain

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

317-322

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

1

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer

2

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Potential for radiotherapy alone in prostatic cancer

3

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Selecting initial therapy for prostate cancer. Radiation therapy perspective

4

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Total Perineal Prostatectomy for Carcinoma of the Prostate

7

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique

9

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function

10

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Staging errors in clinically localized prostatic cancer

11

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Proceedings: Radical prostatectomy in the treatment of prostatic cancer.

12

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical prostatectomy: osu and affiliated hospitals' experience 1985–1989

13

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases

14

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival

15

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

16

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Adjuvant radiotherapy following radical prostatectomy: results and complications

17

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Total prostatectomy for localized prostatic cancer

18

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

External beam radiation treatment for prostate cancer: still the gold standard

19

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical prostatectomy or radiation therapy for early prostate cancer. Two roads to the same end

20

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States

21

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Postoperative radiation therapy for pathologic stage C prostate cancer

22

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical Prostatectomy in the Management of Carcinoma of the Prostate: Probable Causes of Some Therapeutic Failures

23

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup.

24

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade

25

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.

26

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

The value of serum prostate specific antigen determinations before and after radical prostatectomy

27

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy

28

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence

29

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Postoperative radiation therapy after radical prostatectomy for prostate carcinoma

30

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical prostatectomy for stage B2 prostatic cancer

31

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

32

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

33

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

34

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Tumor control in definitive irradiation of localized carcinoma of the prostate

35

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview

36

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radiotherapy for localized prostate carcinoma

38

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens

39

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

41

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical retropubic prostatectomy for cancer: a 20-year experience

42

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Radical Surgery for Prostatic Cancer

43

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy

44

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate

45

1 reference

10.1016/0360-3016(94)90010-8

https://api.crossref.org/works/10.1016/0360-3016(94)90010-8

16 May 2024

Identifiers

10.1016/0360-3016(94)90010-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523342%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71650601&oldid=2155996996"